QA: Edesa Biotech Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001540159_2021_Edesa_Biotech_Inc.pdf

Logs

Graph

Absolute values for 0001540159, Edesa Biotech Inc

  xvar xval
0 AssetsCurrent 8,104,018
1 IntangibleAssetsNetIncludingGoodwill 2,483,536
2 PropertyPlantAndEquipmentNet 14,815
3 remainder_Assets 160,006
4 LiabilitiesCurrent 1,529,857
5 LiabilitiesNoncurrent 94,460
6 remainder_Liabilities 29,928
7 CostOfGoodsAndServicesSold 5,479
8 SellingGeneralAndAdministrativeExpense 3,473,959
9 ResearchAndDevelopmentExpense 2,903,238
10 remainder_Expenses 101,333
11 remainder_Revenues 317,469
12 remainder_NetIncome 38,649
13 remainder_ComprehensiveNetIncome 54,870
  yvar yval
0 Assets 10,762,375
1 Liabilities 1,654,245
2 Expenses 6,484,009
3 Revenues 317,469
4 StockholdersEquity 9,108,130
5 NetIncome -6,127,891
6 ComprehensiveNetIncome -6,100,456
7 BaseVar 9,655,808
8 EconomicCapitalRatiobeforeLimitedLiability 2.22
9 EconomicCapitalRatio 3.17

Edgar->Model Mapping

Feature Distribution

Change over Time